Category: LP News

0 814

The Green Organic Dutchman Reports First Quarter 2021 Results

Revenue of $8.98 million increased 194% compared to Q1-2020 Gross profit of $3.13 million increased 83%…

 Leave a comment    Posted in Earnings, LP News Tagged ,
0 1184

High Tide Announces Details of Consolidation to Meet Nasdaq Listing Requirements

15:1 share consolidation to begin trading on or about May 14, 2021 NASDAQ Capital Market listing expected…

 Leave a comment    Posted in LP News Tagged
0 5617

Aleafia Health Reports 2021 First Quarter Results

Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) is pleased to…

 Leave a comment    Posted in LP News Tagged
0 776

InterCure Announces Preliminary First Quarter Record Financial Results

InterCure Ltd. (TSX: INCR:U, TASE: INCR)(dba Canndoc)(the “Company”) today announced preliminary financial results for the…

 Leave a comment    Posted in Earnings, LP News Tagged , ,
0 1094

HEXO Corp to Participate in Canaccord Genuity’s 5th Annual Global Cannabis Conference on May 11, 2021

HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NYSE: HEXO) today announced that Sebastien St-Louis,…

 Leave a comment    Posted in LP News Tagged
0 1242

The Green Organic Dutchman Holdings to Release First Quarter 2021 Financial Results on May 12

The Green Organic Dutchman Holdings Ltd. (“TGOD” or the “Company”) (TSX: TGOD) (US: TGODF), a leading…

 Leave a comment    Posted in Earnings, LP News Tagged
0 1243

Cronos Group Reports 2021 First Quarter Results

Receives processing license for the commercial production and sale of cannabinoids using biosynthesis Announces plans…

 Leave a comment    Posted in LP News Tagged ,
0 1354

Delta 9 Provides Guidance & Timing for Q1 2021 Results

DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: DLTNF) (“Delta 9” or the “Company”) is pleased…

 Leave a comment    Posted in Earnings, LP News Tagged ,
0 674

InMed Pharmaceuticals to Report Third Quarter Fiscal 2021 Financial Results

InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (NASDAQ:INM; TSX:IN), a clinical-stage company developing pharmaceutical-based drug candidates…

 Leave a comment    Posted in Earnings, LP News Tagged ,
0 1189

The Valens Company Announces Appointments to Management Team and Nominations to Board of Directors

 The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the “Company,” “The Valens Company” or “Valens”), a…

 Leave a comment    Posted in LP News Tagged